Related Experiment Video
Updated: Jul 17, 2025

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
Published on: May 10, 2016
CHAC1 exacerbates arsenite cytotoxicity by lowering intracellular glutathione levels
Daigo Sumi1, Hiroki Taguchi1, Kumiko Takeuchi1
1Faculty of Pharmaceutical Sciences, Tokushima Bunri University.
Insights
CHAC1 regulates intracellular glutathione (GSH) levels, influencing sensitivity to arsenite (As(III)) in HaCaT cells. Downregulating CHAC1 reduces As(III)-induced apoptosis, highlighting CHAC1
Area of Science:
- Cell Biology
- Toxicology
- Biochemistry
Background:
- Arsenite (As(III)) is a toxic metalloid known to induce cytotoxicity and apoptosis in various cell types.
- Glutathione (GSH) plays a critical role in cellular defense against oxidative stress and toxic insults.
- CHAC1 (also known as AIG1) is a gene induced by endoplasmic reticulum stress and implicated in apoptosis.
Purpose of the Study:
- To investigate the role of CHAC1 in arsenite (As(III))-induced cytotoxicity and apoptosis in HaCaT cells.
- To determine the relationship between CHAC1 expression, intracellular GSH levels, and As(III) sensitivity.
Main Methods:
- HaCaT cells were transfected with CHAC1 siRNA to reduce CHAC1 expression.
- Cells were treated with arsenite (As(III)) and/or buthionine sulfoximine (BSO), an inhibitor of GSH biosynthesis.
- Intracellular GSH levels, cell viability, and apoptosis (caspase-3 cleavage) were assessed.
Main Results:
- Downregulation of CHAC1 led to decreased sensitivity to As(III)-induced cytotoxicity.
- Elevated intracellular GSH levels in CHAC1-depleted cells correlated with reduced As(III) sensitivity.
- As(III) exposure increased CHAC1 expression and induced apoptosis, which was abrogated in CHAC1 siRNA-transfected cells.
Conclusions:
- CHAC1 is involved in regulating intracellular GSH levels, thereby modulating HaCaT cell sensitivity to arsenite.
- CHAC1 plays a significant role in As(III)-induced apoptosis in HaCaT cells.
- Targeting CHAC1 may offer a strategy to mitigate arsenite toxicity.
Abstract:
We here examined whether CHAC1 is implicated in arsenite (As(III))-induced cytotoxicity in HaCaT cells. We found that HaCaT cells in which the intracellular GSH levels were elevated by transfection with CHAC1 siRNA showed decreased sensitivity to As(III) compared to the control cells. Treatment with BSO (an inhibitor of GSH biosynthesis) abolished the decrease in sensitivity to As(III), suggesting that an increase in intracellular GSH levels was involved in the decrease in sensitivity to As(III) due to the decrease in the levels of CHAC1 expression. When we examined the expression of CHAC1 after exposure of HaCaT cells to As(III), the levels of CHAC1 were increased. Since CHAC1 is a proapoptotic factor, we examined appearance of apoptotic cells and cleavage of caspase-3 after exposure to As(III) to determine whether As(III)-induced CHAC1 up-regulation was involved in apoptosis induction. The results showed that induction of apoptosis by As(III) exposure was not detected in CHAC1 siRNA-transfected cells. Together, our findings indicate that CHAC1 is involved in the sensitivity of HaCaT cells to As(III) by regulating the intracellular GSH levels, and in particular, CHAC1 is involved in As(III)-induced apoptosis.
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Direct-Acting Cholinergic Agonists: Pharmacokinetics

